Literature DB >> 32267650

Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19.

Mark A Lewis1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32267650     DOI： 10.1056/NEJMp2006588

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  Considerations for cancer immunotherapy biomarker research during COVID-19.

Authors:  Jennifer W Carlisle; Caroline S Jansen; Mehmet Asim Bilen; Haydn Kissick
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.678

2.  Impact of COVID-19 Pandemic on Gynecological Oncology Care: Glimpse into Association of Gynecological Oncologists of India (AGOI) Perspective.

Authors:  Geetu Bhandoria; T S Shylasree; Prashant Bhandarkar; Vijay Ahuja; Amita Maheshwari; Rupinder Sekhon; S P Somashekhar
Journal:  Indian J Gynecol Oncol       Date:  2020-06-15

3.  Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey.

Authors:  Elissar Moujaess; Naji Bou Zeid; Ramy Samaha; Joud Sawan; Hampig Kourie; Chris Labaki; Roy Chebel; Georges Chahine; Fadi El Karak; Fadi Nasr; Marwan Ghosn; Jad Wakim; Joseph Kattan
Journal:  Future Oncol       Date:  2021-08-02       Impact factor: 3.404

4.  COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.

Authors:  Gagandeep Brar; Laura C Pinheiro; Michael Shusterman; Brandon Swed; Evgeniya Reshetnyak; Orysya Soroka; Frank Chen; Samuel Yamshon; John Vaughn; Peter Martin; Doru Paul; Manuel Hidalgo; Manish A Shah
Journal:  J Clin Oncol       Date:  2020-09-28       Impact factor: 44.544

5.  Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report.

Authors:  S Gill; D Hao; H Hirte; A Campbell; B Colwell
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

6.  The blurred line between the art and science of medicine.

Authors:  Alexia Francesca Bertuzzi; Nicolò Gennaro; Andrea Marrari; Armando Santoro
Journal:  Radiother Oncol       Date:  2020-05-28       Impact factor: 6.280

7.  ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.

Authors:  Antonio Passaro; Alfredo Addeo; Christophe Von Garnier; Fiona Blackhall; David Planchard; Enriqueta Felip; Rafal Dziadziuszko; Filippo de Marinis; Martin Reck; Hasna Bouchaab; Solange Peters
Journal:  ESMO Open       Date:  2020-06

8.  Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.

Authors:  Laila A Gharzai; Kenneth Resnicow; Lawrence C An; Reshma Jagsi
Journal:  JAMA Oncol       Date:  2020-09-01       Impact factor: 31.777

9.  How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.

Authors:  Giulia Pasello; Jessica Menis; Sara Pilotto; Stefano Frega; Lorenzo Belluomini; Federica Pezzuto; Anna Caliò; Matteo Sepulcri; Nunzia Luna Valentina Cernusco; Marco Schiavon; Maurizio Valentino Infante; Marco Damin; Claudio Micheletto; Paola Del Bianco; Riccardo Giovannetti; Laura Bonanno; Umberto Fantoni; Valentina Guarneri; Fiorella Calabrese; Federico Rea; Michele Milella; PierFranco Conte
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

10.  False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis.

Authors:  Argyrios Tzouvelekis; Theodoros Karampitsakos; Anastasia Krompa; Evangelos Markozannes; Demosthenes Bouros
Journal:  Front Med (Lausanne)       Date:  2020-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.